federal_register: 2018-26029

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
2018-26029 Bone, Reproductive and Urologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments Notice The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee. The general function of the committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document. 2018-11-30 2018 11 https://www.federalregister.gov/documents/2018/11/30/2018-26029/bone-reproductive-and-urologic-drugs-advisory-committee-notice-of-meeting-establishment-of-a-public https://www.govinfo.gov/content/pkg/FR-2018-11-30/pdf/2018-26029.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee. The general function of the committee is to provide advice and recommendations to FDA on...

Links from other tables